Ariana Pharma – Artificial Intelligence for Precision Medicine

Meet KEM®

Ariana has developed KEM® (Knowledge Extraction and Management) the most advanced Artificial Intelligence platform based on Galois Lattices (also known as Formal Concept Analysis or FCA). KEM® uses association rules to fully explore complex datasets in order to reveal hidden relationships and to derive new hypotheses.

Fast-Track clinical trials
Identify best responders
Spot optimal endpoints

Our approach

Customers

Join the leading global pharma, biotech and healthcare companies who benefit from our expertise.

READ

Partners

Learn more about our international collaborative research and development projects.

BROWSE

Technology

Discover how our KEM® Artificial Intelligence platform provides a unique approach to fully explore complex datasets.

Latest News

605, 2021

Ariana appoints pharmaceutical industry drug development veteran, Hichem Chakroun, Executive VP Clinical Development, as the company expands Precision Medicine collaborations

Paris, France and Cambridge, MA, USA. May 6th 2021. Ariana, a leading eXplainable Artificial Intelligence (AI) drug development company, is delighted to announce the appointment of Dr. Hichem Chakroun as [...]

2904, 2021

Ariana Pharma announces an Artificial Intelligence-driven Precision Medicine collaboration with Sanofi and leading academic partners targeting autoimmune and inflammatory diseases associated with primary immune deficiencies.

Explainable Artificial Intelligence and multi-omic investigations in autoimmune and inflammatory diseases Paris, France and Cambridge, MA, USA, April 29th, 2020. Ariana® Pharma a leading Artificial Intelligence drug development company announced today [...]

2110, 2020

Ariana Pharma Announces Appointment of Accomplished Business and Strategy Executive, Kia Motesharei to its Board of Directors.

Paris and Boston, October 21st, 2020. Ariana® Pharma a leading digital health company today announced the appointment of Kia Motesharei, PhD to its board of directors. Dr. Motesharei joins existing [...]

Fast-track your clinical trials

Contact Us

We explore deeper to find the best biomarkers

Our KEM® platform is the only FDA-tested technology that explores the entire combinatorial space, and guides you to the most cost-effective biomarkers.

We look closer to maximize clinical trial success rates

Our FDA-tested KEM® technology helps secure product approval .

We discover more with KEM®

KEM®, our Artificial Intelligence, finds hidden signals and complex relationships that conventional statistical analyses miss.

We Fast-track your clinical trials

We identify best Responders and optimal Endpoints.